Results of curative therapy for XXXX in a community training hospital.

@entity5 @entity1 @entity189 @entity418
A 12-year experience of therapy for @entity418 in a community-based @entity5 center was reviewed retrospectively. Of a total of 88 @entity1 with histologically proven @entity189 30 (34.1%) underwent curative esophagectomy. Twelve @entity1 received preoperative chemoradiotherapy. Fourteen esophagectomies were performed transhiatally and 16 via the thoracolaparotomy approach. The average distance from incisors was 32.2 and 32.1 cm, respectively. Overall morbidity was 36.7%, with major complications in 30% of @entity1 . Mortality was 3.3%. A comparison of @entity1 treated with preoperative chemoradiotherapy (12 @entity1 ) and surgery alone (18 @entity1 ) showed no statistical difference in morbidity, mortality, or length of hospital stay. Analysis of these parameters in groups of @entity1 operated via the transhiatal versus thoracolaparotomy approach demonstrated statistically lower morbidity (14.3% versus 56.3%, respectively), with no difference in mortality and a trend toward a shorter hospital stay in the former group. Overall survival at 3 years was 63.9%. In the combined therapy group, 90.9% of @entity1 survived 3 years compared to 40.4% in the surgery only group (P = 0.0177). There was a trend toward better survival in the group of @entity1 treated via the transhiatal approach. This study demonstrated that curative therapy for @entity418 can be performed with acceptable morbidity and mortality in a community teaching hospital.
